Riskpilot← Back to searchSign inGet full accessSanmed AB
ABActiveOrg 5568619778Karl Gustavsgatan 18 AOther human health activities n.e.c. · NACE 8699Est. 20111-4 employees
Revenue 2025
SEK 1M
-1% vs 2024
EBITDA margin
87.2%
+2% vs 2024
Equity ratio
51.9%
Financial strength
Net profit 2025
SEK 530K
+1% vs 2024
| Revenue | SEK 1M | -1% |
| EBITDA | SEK 898K | +2% |
| Net profit | SEK 530K | +1% |
| Total assets | SEK 1,8M | +53% |
| Equity | SEK 916K | +56% |
| Employees | — | — |
Legal name
Sanmed AB
Org number
5568619778
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
22 augusti 2011
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet ska vara att bedriva konsultverksamhet inom området medicin, rådgivning och utbildning inom medicin, utveckla och marknadsföra hälsovårdsprodukter och förvaltning av värdepapper och fastigheter samt bedriva därmed förenlig verksamhet.
Address
Karl Gustavsgatan 18 A
Email
mikael.sansone@gmnail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 21 | 74 | 1 042 | 1 030 |
| Staff expenses | — | — | −10 | −39 | −13 |
| EBITDA | −178 | −7 | 20 | 883 | 898 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −178 | −7 | 20 | 883 | 898 |
| Net financials | — | — | 0 | 1 | −4 |
| Profit before tax | 7 | 0 | 124 | 664 | 669 |
| Tax | −4 | −0 | −27 | −137 | −139 |
| Net profit | 3 | 0 | 97 | 527 | 530 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 710 | 454 | 270 | 1 151 | 1 765 |
| Equity | 571 | 342 | 249 | 586 | 916 |
| Long-term debt | 1 | 0 | 1 | 1 | 8 |
| Short-term debt | 24 | 8 | 20 | 343 | 396 |
| Total debt | 25 | 8 | 21 | 344 | 404 |
EBITDA margin
87.2%
This company
15.8%
Market median
+452% vs market
20212025
Equity ratio
51.9%
This company
38.2%
Market median
+36% vs market
20212025
Return on equity
57.8%
This company
18.4%
Market median
+214% vs market
20212025
Net profit margin
51.5%
This company
8.1%
Market median
+536% vs market
20212025
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20212025
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sanmed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Saga Giuseppina Sansone | Deputy Board Member | 0 companies |
| Martina Charlotta Wahllöf | Deputy Board Member | 0 companies |
| Ida Ellinor Leipe | Deputy Board Member | 0 companies |
| Mikael Sansone | Board of Directors | 0 companies |